The level of malondialdehyde-modified LDL and LDL immune complexes in patients with rheumatoid arthritis

Junjun Wang1, Bing Hu, Yang Meng

  • 1Department of Biochemistry, Jinling Hospital, Clinical School of Medical College, Nanjing University, 305#, East Zhong Shan Road, Nanjing, 210002, PR China. wangjj6@jlonline.com

Abstract

Insights

High levels of malondialdehyde-modified low-density lipoprotein (MDA-LDL) and LDL-immune complexes (LDL-IC) are linked to atherosclerosis in rheumatoid arthritis (RA) patients. These markers are associated with inflammation and indicate increased cardiovascular risk.

Area of Science:

  • Cardiovascular Research
  • Rheumatology
  • Biochemistry

Background:

  • Rheumatoid arthritis (RA) is associated with an increased risk of atherosclerosis.
  • The specific roles of modified lipoproteins in RA-related cardiovascular disease require further elucidation.

Purpose of the Study:

  • To investigate the association between malondialdehyde-modified low-density lipoprotein (MDA-LDL) and LDL-immune complexes (LDL-IC) with atherosclerosis in rheumatoid arthritis (RA) patients.

Main Methods:

  • Plasma levels of MDA-LDL and LDL-IC were measured in RA patients with or without coronary artery disease (CAD), patients with simple CAD, and healthy controls.
  • Statistical analyses, including multiple linear regression, were employed to identify factors influencing MDA-LDL and LDL-IC levels.

Main Results:

  • MDA-LDL and LDL-IC levels were elevated in all patient groups, with the highest levels observed in RA patients who also had CAD.
  • MDA-LDL levels were significantly higher in RA patients with CAD compared to those with RA alone or CAD alone.
  • CAD, LDL-IC, and erythrocyte sedimentation rate explained 36.5% of the variation in MDA-LDL levels. Age, disease activity, MDA-LDL, and rheumatoid factors explained 34.5% of the variation in LDL-IC.

Conclusions:

  • Elevated MDA-LDL and LDL-IC are significant risk factors for atherosclerosis in RA patients.
  • These modified lipoproteins are associated with inflammation, contributing to the heightened cardiovascular risk observed in RA.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Inflammation01:38

Inflammation

Overview